105 related articles for article (PubMed ID: 9605411)
1. Production and characterization of group-specific monoclonal antibodies recognizing nonamidated, glycine- and taurine-amidated ursodeoxycholic acid 7-N-acetylglucosaminides.
Kobayashi N; Oiwa H; Goto J
J Steroid Biochem Mol Biol; 1998 Feb; 64(3-4):171-7. PubMed ID: 9605411
[TBL] [Abstract][Full Text] [Related]
2. A monoclonal antibody-based enzyme-linked immunosorbent assay of ursodeoxycholic acid 3-sulfates in human urine.
Kobayashi N; Katsumata H; Katayama H; Oiwa H; Goto J; Takeuchi Y
J Steroid Biochem Mol Biol; 2000 Apr; 72(5):265-72. PubMed ID: 10822016
[TBL] [Abstract][Full Text] [Related]
3. Idiotype-anti-idiotype-based noncompetitive enzyme-linked immunosorbent assay of ursodeoxycholic acid 7-N-acetylglucosaminides in human urine with subfemtomole range sensitivity.
Kobayashi N; Kubota K; Oiwa H; Goto J; Niwa T; Kobayashi K
J Immunol Methods; 2003 Jan; 272(1-2):1-10. PubMed ID: 12505707
[TBL] [Abstract][Full Text] [Related]
4. N-acetylglucosaminides. A new type of bile acid conjugate in man.
Marschall HU; Egestad B; Matern H; Matern S; Sjövall J
J Biol Chem; 1989 Aug; 264(22):12989-93. PubMed ID: 2753897
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies generated against an affinity-labeled immune complex of an anti-bile acid metabolite antibody: an approach to noncompetitive hapten immunoassays based on anti-idiotype or anti-metatype antibodies.
Kobayashi N; Oiwa H; Kubota K; Sakoda S; Goto J
J Immunol Methods; 2000 Nov; 245(1-2):95-108. PubMed ID: 11042287
[TBL] [Abstract][Full Text] [Related]
6. [Measurement of bile acid N-acetylglucosaminides in serum and urine of patients with chronic liver diseases during ursodeoxycholic acid treatment].
Kimura A; Nakamura K; Makino I
Nihon Shokakibyo Gakkai Zasshi; 1995 Mar; 92(3):224-32. PubMed ID: 7731091
[TBL] [Abstract][Full Text] [Related]
7. Generation of a novel monoclonal antibody against cortisol-[C-4]-bovine serum albumin conjugate: application to enzyme-linked immunosorbent assay for urinary and serum cortisol.
Kobayashi N; Sun P; Fujimaki Y; Niwa T; Nishio T; Goto J; Hosoda H
Anal Sci; 2002 Dec; 18(12):1309-14. PubMed ID: 12502080
[TBL] [Abstract][Full Text] [Related]
8. Conjugation types of 7 beta-hydroxylated bile acids detected in healthy human urine.
Yamaga N; Kohara H
J Biochem; 1994 Nov; 116(5):1123-6. PubMed ID: 7896741
[TBL] [Abstract][Full Text] [Related]
9. Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment.
Chretien Y; Poupon R; Gherardt MF; Chazouilleres O; Labbe D; Myara A; Trivin F
Gut; 1989 Aug; 30(8):1110-5. PubMed ID: 2767508
[TBL] [Abstract][Full Text] [Related]
10. Production and characterization of monoclonal antibodies against a novel 1alpha,25-dihydroxyvitamin D3-bovine serum albumin conjugate linked through the 11alpha-position.
Kobayashi N; Imazu T; Ebisawa A; Shimada K
J Steroid Biochem Mol Biol; 1997; 63(1-3):127-37. PubMed ID: 9449214
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody-based enzyme-linked immunosorbent assay of glycolithocholic acid sulfate in human urine for liver function test.
Kobayashi N; Katsumata H; Uto Y; Goto J; Niwa T; Kobayashi K; Mizuuchi Y
Steroids; 2002 Sep; 67(10):827-33. PubMed ID: 12231118
[TBL] [Abstract][Full Text] [Related]
12. Production and characterization of monoclonal antibodies against two haptenic derivatives of 1 alpha,25-dihydroxyvitamin D3 conjugated with bovine serum albumin through the C-3 or C-24 position.
Kobayashi N; Sato A; Takagi K; Shimada K
Biol Pharm Bull; 1997 Sep; 20(9):948-53. PubMed ID: 9331974
[TBL] [Abstract][Full Text] [Related]
13. Enantioselective Monoclonal Antibodies for Detecting Ketamine to Crack Down on Illicit Use.
Morita I; Oyama H; Kanda Y; Yasuo M; Ito A; Toyota M; Hayashi Y; Yokoyama T; Kobayashi N
Biol Pharm Bull; 2018; 41(1):123-131. PubMed ID: 29311474
[TBL] [Abstract][Full Text] [Related]
14. One-step monoclonal antibody based enzyme-linked immunosorbent assay for direct determination of cortisol in serum.
Liu R; Chen F; Zou K; Yang T
Hybridoma (Larchmt); 2011 Jun; 30(3):279-86. PubMed ID: 21707363
[TBL] [Abstract][Full Text] [Related]
15. Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health.
Dilger K; Hohenester S; Winkler-Budenhofer U; Bastiaansen BA; Schaap FG; Rust C; Beuers U
J Hepatol; 2012 Jul; 57(1):133-40. PubMed ID: 22414767
[TBL] [Abstract][Full Text] [Related]
16. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
Combes B; Carithers RL; Maddrey WC; Munoz S; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White H; Zetterman RK; Risser R; Rossi SS; Hofmann AF
Hepatology; 1999 Jun; 29(6):1649-54. PubMed ID: 10347103
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of N-acetylglucosaminides of unconjugated and conjugated bile acids.
Niwa T; Koshiyama T; Goto J; Nambara T
Steroids; 1992 Nov; 57(11):522-9. PubMed ID: 1448811
[TBL] [Abstract][Full Text] [Related]
18. The choleretic effects of N-acetylglucosaminides, major urinary metabolites of ursodeoxycholic acid, in bile fistula rats.
Iwaki T; Hirabayashi N; Miyazawa N; Takeuchi Y; Ishizaki K; Sakakura H; Kasai H; Maeda M; Araki T
Eur J Pharmacol; 1998 Dec; 363(1):41-8. PubMed ID: 9877080
[TBL] [Abstract][Full Text] [Related]
19. Increase of sulfated ursodeoxycholic acid in the serum and urine of patients with chronic liver disease after ursodeoxycholic acid therapy.
Nakamura K; Yoneda M; Kimura A; Tamori K; Yokohama S; Sato Y; Kato T; Hasegawa T; Saito H; Aoshima M; Fujita M; Makino I
J Gastroenterol Hepatol; 1996 Apr; 11(4):385-90. PubMed ID: 8713707
[TBL] [Abstract][Full Text] [Related]
20. Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate.
Rudolph G; Kloeters-Plachky P; Sauer P; Stiehl A
Eur J Clin Invest; 2002 Aug; 32(8):575-80. PubMed ID: 12190957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
